SCHEMBL9446972

SCHEMBL9446972

O=S(=O)(Nc1cccc(Oc2cccc3cccnc23)c1)c1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 4/20 0.61
▸ GAA P10253 1/20 0.61
▸ GLRA3 O75311 1/20 0.57
▸ F2 P00734 1/20 0.54
▸ MMP2 P08253 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ HPGD P15428 2/20 0.54
▸ HSP90AA1 P07900 1/20 0.53
▸ HSP90AB1 P08238 1/20 0.53
▸ FFAR4 Q5NUL3 2/20 0.52
▸ CACNA1H O95180 1/20 0.52
▸ CACNA1B Q00975 1/20 0.52
▸ GPR119 Q8TDV5 1/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CKS1B P61024 1/20 0.49
▸ SKP2 Q13309 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ SLC40A1 Q9NP59 1/20 0.49
▸ FFAR1 O14842 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446974 0.90 SLC40A1 (0.60) GAAF2ALDH1A1GPR119MEN1
SCHEMBL9447008 0.90 GLO1 (0.62) GLO1GAAGLRA3MMP2ALDH1A1
SCHEMBL9446958 0.84 SLC40A1 (0.65) GLO1FFAR4KMT2ACKS1BSKP2
SCHEMBL9446966 0.84 GLRA3 (0.60) GLO1GAAGLRA3F2MMP2
SCHEMBL10654161 0.83 GAA (0.60) GLO1GAAF2ALDH1A1HPGD
SCHEMBL9447001 0.81 GLO1 (0.75) GLO1GLRA3MMP2ALDH1A1HPGD
SCHEMBL9447198 0.80 KMT2A (0.61) GLO1GAAALDH1A1HPGDGPR119
SCHEMBL7208902 0.77 KDM4E (0.54) GAAGLRA3ALDH1A1HPGDMEN1
SCHEMBL9446984 0.77 MEN1 (0.71) GLO1GAAALDH1A1HPGDGPR119
SCHEMBL6978005 0.76 GLO1 (1.00) GLO1MMP2ALDH1A1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202336-A Lipoxygenase inhibitors BAYER AKTIENGESELLSCHAFT (DE) 1993-04-13 — — US disclosed
US-5093340-A Lipoxygenase enzyme inhibitors, antithrombolytic agents BAYER AKTIENGESELLSCHAFT (DE) 1992-03-03 — — US disclosed
US-5070096-A ANTICOAGULANTS, LIPOXYGENASE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1991-12-03 — — US disclosed
EP-0261539-A2 Substituted phenyl-sulphon amides BAYER AG (DE) 1988-03-30 — — EP disclosed
Send feedback